Document Classification

Section Type: RESULTS

Text: Mean reduction in glycemic parameters at Week 12 (HbA1c : -0. 56 % vs -0. 72 %, p = 0. 394 ; FBG : -0. 99 mmol/L vs -1. 05 mmol/L, p = 0. 878 ; PPG : -1. 93 mmol/L vs -1. 52 mmol/L, p = 0. 423) and Week 24 (HbA1c : -0. 87 % vs -0. 90 %, p = 0. 909 ; FBG : -0. 79 mmol/L vs -1. 02 mmol/L, p = 0. 648 ; PPG : -1. 77 mmol/L vs -1. 36 mmol/L, p = 0. 415) was not significantly different between the hydroxychloroquine and pioglitazone groups.